Family · Pharmaceutical analytical standards
Naloxegol
A peripherally acting mu-opioid receptor antagonist, approved in 2014 for opioid-induced constipation in adults with chronic non-cancer pain. This family brings together the active ingredient.
Did you know?It is a naloxol molecule linked to a polyethylene glycol (PEG) chain: this tail stops it from crossing the blood-brain barrier, so it acts on the gut but not on the brain.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
